These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17713032)

  • 1. Ignore FDA reform at your peril.
    Fulton A
    AHIP Cover; 2007; 48(4):8, 54. PubMed ID: 17713032
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA has a change of heart.
    Neil R
    Mater Manag Health Care; 2006 May; 15(5):9. PubMed ID: 16761870
    [No Abstract]   [Full Text] [Related]  

  • 3. Getting the bad news about your artificial heart valve.
    Fielder JH
    Hastings Cent Rep; 1993; 23(2):22-8. PubMed ID: 8463086
    [No Abstract]   [Full Text] [Related]  

  • 4. In search of a coherent framework: options for FDA oversight of genetic tests.
    Javitt GH
    Food Drug Law J; 2007; 62(4):617-52. PubMed ID: 18557224
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA considering new rules that may clamp down on early showings of works in progress.
    Wagner M
    Mod Healthc; 1992 Aug; 22(32):34. PubMed ID: 10119785
    [No Abstract]   [Full Text] [Related]  

  • 6. Europe and FDA agree to limited inspections.
    Fox JL
    Nat Biotechnol; 1997 Aug; 15(8):714-5. PubMed ID: 9333519
    [No Abstract]   [Full Text] [Related]  

  • 7. New US agent requirements.
    Donawa M
    Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closing the loopholes in the regulation of medical devices: the need for Congress to reevaluate medical device regulation.
    VanBuren M
    Health Matrix Clevel; 2007; 17(2):441-65. PubMed ID: 18326398
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA import alert: a potentially devastating enforcement tool.
    Basile EM
    Med Device Technol; 1998 Apr; 9(3):34-8. PubMed ID: 10179199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA proposes "regulatory science" initiatives.
    Nurse Educ; 2011; 36(2):75. PubMed ID: 21330898
    [No Abstract]   [Full Text] [Related]  

  • 11. Transparent reaction. Suppliers oppose FDA move to disclose more data.
    Rhea S
    Mod Healthc; 2010 Jul; 40(30):16. PubMed ID: 20695055
    [No Abstract]   [Full Text] [Related]  

  • 12. The Center for Devices and Radiological health: an update.
    Donawa M
    Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life in the slow lane at the FDA.
    Wagner M
    Mod Healthc; 1993 Feb; 23(5):35-6, 40, 42. PubMed ID: 10123705
    [No Abstract]   [Full Text] [Related]  

  • 14. Caution flags. Industry fears implications of new FDA process.
    Rhea S
    Mod Healthc; 2010 Jun; 40(26):12-3. PubMed ID: 20632728
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA urged to replace 510(k) process.
    OR Manager; 2011 Sep; 27(9):5. PubMed ID: 21998893
    [No Abstract]   [Full Text] [Related]  

  • 17. Is consensus regulation possible?
    Miller MJ
    Med Instrum; 1979; 13(6):358. PubMed ID: 522721
    [No Abstract]   [Full Text] [Related]  

  • 18. US market: 2008 priorities.
    Novelli T
    Med Device Technol; 2008; 19(3):58. PubMed ID: 18557412
    [No Abstract]   [Full Text] [Related]  

  • 19. Does the FDA have authority to regulate human cloning?
    Price EC
    Harv J Law Technol; 1998; 11(3):619-41. PubMed ID: 12731551
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding US labelling requirements.
    Donawa M
    Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.